🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sara Hamon

Regeneron (United States)

ORCID: 0000-0002-2413-2302

Also affiliated with Progenics Pharmaceuticals (United States)

NeuroscienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies”.

The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies

Cell(2021)10.1016/j.cell.2021.06.002

N/A

0DataRank · unranked

240 citations

Alina Baum, Elzbieta Wloga, Kristen E. Pascal, Stephanie Giordano, Benjamin O. Fulton +32 more

CLINICAL RESPONSES TO ODRONEXTAMAB (REGN1979): CORRELATION WITH LOSS OF CD20 EXPRESSION AS A POTENTIAL MECHANISM OF RESISTANCE AND BASELINE BIOMARKERS OF TUMOR T CELLS

Hematological Oncology(2021)10.1002/hon.6_2880

N/A

0DataRank · unranked

1 citations

Nathalie Fiaschi, Raquel P. Deering, Ankur Dhanik, Kamil J. Cygan, W Zhang +19 more

Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene

European Journal of Clinical Pharmacology(2022)10.1007/s00228-022-03302-5

N/A

0DataRank · unranked

3 citations

Robrina Walker, David P. Graham, Ellen M. Nielsen, Sara Hamon, Maureen Hillhouse +10 more